Michele Jen
About Michele Jen
Michele Jen serves as the Associate Director at Sangamo Therapeutics, Inc. since 2020, bringing extensive experience in biomedical engineering and project management from previous roles at Alcon, Neurogene Inc., and other organizations.
Work at Sangamo Therapeutics
Michele Jen has been serving as Associate Director at Sangamo Therapeutics, Inc. since 2020. In this role, she contributes to the company's mission of developing genomic therapies for serious diseases. Her responsibilities include overseeing projects and collaborating with cross-functional teams to advance therapeutic candidates through various stages of development.
Previous Experience at Alcon
Prior to her current position, Michele Jen worked at Alcon, a Novartis company, in several roles. She was a Manager and Project Head from 2016 to 2018 in the Dallas-Fort Worth Area. Additionally, she held the position of Senior Scientist from 2015 to 2016, where she focused on engineering and scientific projects within the organization.
Education and Expertise
Michele Jen has a strong educational background in Biomedical Engineering. She earned her Bachelor of Science degree from The University of Texas at Austin from 2003 to 2007. She then pursued further studies at Northwestern University, where she obtained a Master of Science from 2009 to 2011, followed by a Doctor of Philosophy (PhD) from 2011 to 2014.
Career Progression and Roles
Michele Jen's career includes various roles in the biomedical field. She served as Engineering Manager at Patton Surgical Corporation from 2007 to 2008 and later worked as Product Manager at Vax-Immune™ Diagnostics, LLC for six months in 2019. Additionally, she was a Senior Program Manager at Neurogene Inc. from 2019 to 2020, where she managed key projects in the biotechnology sector.